FMA Wealth Management’s AbbVie ABBV Stock Holding History

FMA Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	+883	New	+$190K	0.14%	39
2026 Q1	–	Sell	-933	Closed	-$213K	–	39
2025 Q4	$213K	Sell	933 -50	-5%	-$11.4K	0.14%	45
2025 Q3	$228K	Buy	+983	New	+$200K	0.16%	36
2025 Q2	–	Sell	-983	Closed	-$205K	–	40
2025 Q1	$205K	Buy	+983	New	+$191K	0.16%	40
2024 Q4	–	Sell	-1,083	Closed	-$214K	–	40
2024 Q3	$214K	Buy	+1,083	New	+$202K	0.16%	40

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FMA Wealth Management's ABBV Position: Q2 2026 in Review

FMA Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 883 shares worth $222K. The stake represents 0.14% of the portfolio and ranks #39 among its holdings. This is a return to the name: FMA Wealth Management previously reported a position in ABBV as recently as Q4 2025.

FMA Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 5 quarters since. The position peaked at $228K in Q3 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

FMA Wealth Management held 883 shares of AbbVie worth $222K as of Q2 2026.
AbbVie was a new FMA Wealth Management position in Q2 2026.
AbbVie made up 0.14% of FMA Wealth Management's portfolio in Q2 2026, its #39 holding.
FMA Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 5 quarters since.
FMA Wealth Management's AbbVie position peaked at $228K in Q3 2025.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FMA Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.